Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bornfeld

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Ophthalmology|August 26, 1998
Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 casesS E Coupland, L Krause, H J Delecluse, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1990
[Development and dosimetry of a 125 iodine applicator for brachytherapy of intraocular tumors]W Alberti, B Pothmann, N Bornfeld, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1989
[Dosimetry of ruthenium applicators with an eye phantom and small volume thermoluminescence detectors]K Muskalla, B Pothmann, W Alberti, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Age at diagnosis of isolated unilateral retinoblastoma does not distinguish patients with and without a constitutional RB1 gene mutation but is influenced by a parent-of-origin effectA Schüler, S Weber, M Neuhäuser, et al.
Eye (London, England)|March 27, 2007
Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastasesU Petrausch, P Martus, H Tönnies, et al.
Cancer Research|April 20, 2001
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanomaF Tschentscher, G Prescher, D E Horsman, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.]D Pauleikhoff, B Kirchhof, B Bertram, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Klinische Monatsblatter Fur Augenheilkunde|February 23, 2013
[Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012]D Pauleikhoff, B Bertram, F G Holz, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: treatment of diabetic maculopathy (April 2013)], F Ziemssen, H Helbig, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Ophthalmology|August 26, 1998
Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 casesS E Coupland, L Krause, H J Delecluse, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1990
[Development and dosimetry of a 125 iodine applicator for brachytherapy of intraocular tumors]W Alberti, B Pothmann, N Bornfeld, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1989
[Dosimetry of ruthenium applicators with an eye phantom and small volume thermoluminescence detectors]K Muskalla, B Pothmann, W Alberti, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Age at diagnosis of isolated unilateral retinoblastoma does not distinguish patients with and without a constitutional RB1 gene mutation but is influenced by a parent-of-origin effectA Schüler, S Weber, M Neuhäuser, et al.
Eye (London, England)|March 27, 2007
Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastasesU Petrausch, P Martus, H Tönnies, et al.
Cancer Research|April 20, 2001
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanomaF Tschentscher, G Prescher, D E Horsman, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 22, 2011
[New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy.]D Pauleikhoff, B Kirchhof, B Bertram, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Klinische Monatsblatter Fur Augenheilkunde|February 23, 2013
[Anti-VEGF therapy of neovascular age-related macular degeneration: therapeutic strategies status December 2012]D Pauleikhoff, B Bertram, F G Holz, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: treatment of diabetic maculopathy (April 2013)], F Ziemssen, H Helbig, et al.
Pageof 19